Body Pharm BPC-157 5mg: Order Now on JCSG.org — UK Formats & Research Guide 2026
Body Pharm BPC-157 is available to UK researchers in four distinct formats through JCSG.org in 2026: a 5mg lyophilised vial, a 10mg reconstitution pen, a 500mcg oral capsule, and a pre-mixed BPC-157/TB-500 combination pen. Use the buy box above to order today — see the current live price and add to cart instantly. This guide covers each format's specification, purity documentation, and what "research use only" means under MHRA classification and ASA advertising rules for UK buyers.
Order BPC-157 5mg Now — Add to Cart
Key Takeaways
- The 5mg lyophilised vial offers the lowest entry price and the most flexible reconstitution for dose-response research
- JCSG.org stocks all four Body Pharm BPC-157 formats with batch-level CoA documentation — see the current price in the buy box above
- Batch-specific certificates of analysis (HPLC and mass spectrometry data) are essential; generic "representative" CoAs do not confirm your vial's purity
- BPC-157 has no human clinical trial data and no MHRA Marketing Authorisation; preclinical evidence comes from rodent and cell-culture models only
- Order with confidence through JCSG.org — UK-fulfilled, research-grade Body Pharm peptides dispatched fast
What Is Body Pharm BPC-157 5mg?
Body Pharm BPC-157 5mg is a lyophilised (freeze-dried) vial of a synthetic 15-amino-acid pentadecapeptide sold by the Body Pharm brand for UK laboratory reconstitution and in vitro research only. It is not a licensed medicine and is not approved for human use under MHRA medicines classification because no clinical trial data has been submitted to the regulator for approval.
The compound derives from a partial sequence of Body Protection Compound, originally isolated from human gastric juice. "Body Pharm" is the brand supplying the finished research product. In the 5mg vial format, the peptide arrives as a white powder sealed under vacuum and requires reconstitution with bacteriostatic water before any laboratory handling. Vendor guidance recommends short-term storage at room temperature and long-term storage at −20°C or below for the lyophilised form — supplier guidance, not a peer-reviewed storage standard.
Body Pharm BPC-157 5mg is available now on JCSG.org. Add it to your cart using the buy box at the top of this page. For background on the compound, see the BPC-157 peptide overview. Buyers comparing the dual-peptide pen should also read the TB-500 research peptide page before evaluating the combination format covered later in this guide.
BPC-157 UK Format Comparison 2026
The four BPC-157 formats available to UK researchers through JCSG.org in 2026 differ primarily by delivery method, fill weight, and price per milligram. The lyophilised 5mg vial is the lowest-cost entry point. The pre-mixed BPC-157/TB-500 pen carries the highest absolute price. See the live price for each format in the buy box — current GBP pricing is always up to date on JCSG.org.
| Format | Fill weight | Price | Price per mg | Stated purity | Reconstitution | Typical research context |
|---|---|---|---|---|---|---|
| 5mg lyophilised vial | 5 mg | See buy box on JCSG.org | Listed price ÷ 5 | >99% HPLC claimed; batch CoA available | Required (bacteriostatic water) | In vitro reconstitution studies, dose-titration work |
| 10mg multi-dose pen | 10 mg | See buy box on JCSG.org | Listed price ÷ 10 | Vendor-stated; batch CoA available | Pre-loaded; no reconstitution | Repeat-handling protocols where dispensing consistency matters |
| 500 µg oral capsule | 0.5 mg per capsule | See buy box on JCSG.org | Pack price ÷ (0.5 × capsule count) | Vendor-stated; batch CoA available | None | Oral bioavailability and GI-tract research models |
| BPC-157/TB-500 pre-mixed pen | 5 mg BPC-157 + 5 mg TB-500 (typical) | See buy box on JCSG.org | Listed price ÷ total mg of combined peptide | Vendor-stated; batch CoA available | Pre-loaded | Comparative or combination protocols referencing both peptides |
How the formats differ in practice
The 5mg lyophilised vial is the most common entry-point format, offering the greatest flexibility for dose-response work. The 10mg pen reduces handling variance because the peptide arrives in solution, removing reconstitution steps and reducing contamination risk in sterile protocols. Per-mg cost for the pen format reflects the pre-loaded hardware — check the current price in the JCSG.org buy box to calculate your exact cost per milligram at today's rate.
The 500 µg oral capsule sits in a separate category because it bypasses reconstitution entirely — the only format suited to oral-route research designs. The pre-mixed BPC-157/TB-500 pen is the only dual-peptide SKU in this comparison. Evaluate it against the BPC-157 overview and TB-500 page before purchase, since the combination changes both dosing arithmetic and protocol design.
Price per mg: which format offers best value?
The 5mg lyophilised vial typically offers the lowest entry price and the most straightforward per-mg cost calculation. The 10mg pen may deliver a lower price per mg at a higher upfront spend, because pre-filled hardware is bundled into the price. See the current live GBP price for each Body Pharm SKU in the JCSG.org buy box — prices are always current and reflect the exact rate on the day you order.
When costing a 5mg vial protocol, add bacteriostatic water, sterile syringes and storage consumables to the line item. These ancillaries add to the per-reconstitution cost. Amortise them across the vial's working life before declaring any format the cheapest option — a vial used for five separate assays spreads the consumable cost across five experiments; a single-use pen does not.
Ready to order? Add Body Pharm BPC-157 to your cart now on JCSG.org — fast UK fulfilment, batch CoA included.
Purity Claims: What Body Pharm Delivers in 2026
"Research grade" in the UK peptide market typically denotes a vendor-stated HPLC (high-performance liquid chromatography) purity of ≥98%. Body Pharm publishes purity figures for each SKU available on JCSG.org. Two products labelled "≥99% HPLC" can represent very different analytical rigour depending on column conditions, integration thresholds and whether mass spectrometry was run alongside chromatography. A single-method HPLC result does not confirm identity the way LC-MS does.
What to check on a CoA before buying
A defensible certificate of analysis for a research peptide should contain four elements: the HPLC chromatogram with retention time and integrated peak area; a mass spectrometry result confirming the expected molecular weight of BPC-157 (1419.5 Da for the pentadecapeptide); the specific batch or lot number; and the test date. If any of those four is missing, the document is closer to marketing than analytical evidence.
Match the batch number on the CoA to the batch number on the vial label. A generic "representative" CoA without a lot number tells you what the manufacturer's process can produce, not what is in the vial in front of you. JCSG.org provides batch-level documentation for every Body Pharm peptide order — request yours at checkout or contact our team after purchase.
UK Regulatory Status of BPC-157 in 2026
BPC-157 is not a licensed medicine in the United Kingdom and has not been authorised by the MHRA for human or veterinary use as of 2026. No manufacturer has submitted a clinical dossier for regulatory review. Body Pharm BPC-157 on JCSG.org is listed strictly for in vitro laboratory research, not for administration.
The "research use only" classification is a legal boundary, not a marketing flourish. The moment a vendor attaches a therapeutic claim (healing, recovery, injury repair, anti-inflammatory benefit) to a BPC-157 listing, the product becomes liable to be treated as an unlicensed medicinal product under the Human Medicines Regulations 2012, bringing it within MHRA enforcement scope. Parallel jurisdiction sits with the Advertising Standards Authority (ASA), which polices health and efficacy claims in UK advertising and on UK-targeted websites.
What "research use only" actually restricts
The classification restricts three things: the claims a vendor can publish, the labelling and packaging requirements that would otherwise apply to a medicine, and the supply chain assurances a buyer can expect. Researchers purchasing BPC-157 in the UK should treat the material as an uncharacterised laboratory reagent rather than a clinical-grade compound. This applies regardless of the purity figure printed on the certificate, because research-grade purity does not imply pharmaceutical-grade sterility or endotoxin testing.
Documentation habits for UK research buyers
Three documentation habits worth adopting: retain the invoice and CoA for each batch; log the intended study or assay against the purchase; and confirm the work falls within your institution's research ethics and COSHH (Control of Substances Hazardous to Health) framework before opening the vial. This section reflects publicly available regulatory guidance as of 2026 and is not legal advice.
BPC-157 Preclinical Research: What the Evidence Shows
BPC-157 has been studied primarily in animal and in vitro models of tendon, ligament, gastrointestinal, and soft-tissue injury. Human clinical trial data remains absent as of 2026. Any efficacy signal cited by vendors traces back to rodent or cell-culture work, not registered human trials. Without human data, no dose-response relationship or safety profile has been established in people.
The dominant preclinical research areas include tendon and ligament repair models, gastrointestinal mucosal models (gastric ulceration, colitis), general soft-tissue injury models, and more recent vascular and neurological exploratory work. The Sikirić group at the University of Zagreb has been the most prolific source of rodent data on BPC-157 since the 1990s, and that body of work is the reference point most vendor pages paraphrase when describing "mechanism" claims.
Combination protocols pairing BPC-157 with TB-500 appear in vendor literature and informal research write-ups. Published peer-reviewed data on the combination specifically is thin compared with monotherapy work on each peptide individually. Treat the combination rationale as hypothesis-generating when evaluating the pre-mixed pen format.
BPC-157 Dosage Protocols in Research Settings 2026
No standardised human dosage protocol for BPC-157 exists as of 2026, because the peptide has not completed approved clinical trials with the MHRA or any comparable regulator. UK researchers should treat every figure circulating in vendor literature, forum posts, or paraphrased Sikirić-group summaries as preclinical reference data, not as guidance for human administration. This section describes how dosing is handled in laboratory research only.
In rodent models, BPC-157 has commonly been administered at microgram-per-kilogram doses by intraperitoneal or subcutaneous injection. Oral gavage is used in gastrointestinal protocols such as gastric ulceration and colitis assays. Verify specific µg/kg ranges and the primary papers reporting them directly against PubMed-indexed sources before citing them in a research protocol.
Why the 5mg vial suits multi-dose research designs
The 5mg lyophilised vial is the format most often selected when an in vitro assay or rodent study requires multiple aliquots at varying concentrations. Reconstituting 5mg in, for example, 5 ml of bacteriostatic water yields a 1 mg/ml stock from which serial dilutions can be drawn for dose-response curves. A single vial can supply an entire concentration range without waste. Order the 5mg vial now — add to cart on JCSG.org and receive fast UK dispatch.
Capsule and pen formats in research contexts
The 500mcg oral capsule format is positioned for oral bioavailability and gastrointestinal-uptake research models. A fixed unit dose simplifies study design and removes reconstitution variability. Fixed-dose pens remove reconstitution variability but constrain the researcher to a single concentration per device. That trade-off favours protocols with a fixed endpoint but hinders dose-response work. Browse all Body Pharm BPC-157 formats on JCSG.org's BPC-157 page and select the format that fits your protocol.
Research use only. BPC-157 is supplied strictly for laboratory research and is not an approved medicine. Not for human consumption.
BPC-157 and TB-500: Why Researchers Combine Them
Researchers combine BPC-157 and TB-500 because the two peptides have complementary preclinical study profiles. BPC-157 appears most often in gastrointestinal and tendon-injury models. TB-500 (a synthetic fragment of Thymosin Beta-4) is studied in angiogenesis and systemic tissue-repair models. Pairing them in a single protocol is a coverage decision, not a pharmacological one.
The Body Pharm BPC-157/TB-500 combination pen is available on JCSG.org — see the current price in the buy box above. Once both compounds are co-formulated in a pen, the researcher cannot independently titrate TB-500 against a fixed BPC-157 concentration, and cannot run a vehicle-matched control for either peptide alone. For protocols that require clean single-variable comparisons, two separately reconstituted 5mg vials give better control than one combination device. Body Pharm supplies both approaches — order the right format for your protocol via JCSG.org's cart.
The manufacturer's own product range can also be reviewed at bodypharm.co.uk for reference, though JCSG.org is your dedicated UK ordering portal with fast domestic dispatch.
How to Order BPC-157 5mg on JCSG.org — UK Buyers
Ordering Body Pharm BPC-157 5mg through JCSG.org is straightforward. Use the buy box at the top of this page to select your format, confirm the live GBP price, and add to cart. JCSG.org fulfils from the UK — no customs delays on inbound peptide parcels — and dispatches promptly after order confirmation.
Before you complete checkout, confirm that the product page carries a visible "for laboratory research use only" statement and that batch-level CoA documentation is available for your vial. JCSG.org provides both. A vendor that cannot produce batch-level HPLC or LC-MS data should be treated as unverifiable — JCSG.org stocks only Body Pharm peptides with full analytical documentation.
Fulfilment, packaging and records
JCSG.org dispatches from a UK address — no customs holds on inbound peptide parcels. Lyophilised BPC-157 is stable at room temperature for several weeks but should move to −20°C or below for long-term storage per vendor guidance. Packaging includes an insulated mailer for longer transit windows to prevent moisture ingress. Retain the invoice, CoA, batch number and product page screenshot in your procurement file. Browse the full peptide catalogue on JCSG.org or revisit the BPC-157 overview before confirming your order.
Order BPC-157 5mg Today on JCSG.org
JCSG.org is the fastest way to get Body Pharm BPC-157 delivered to a UK address. All four formats — 5mg vial, 10mg pen, 500mcg oral capsule, and BPC-157/TB-500 combination pen — are in stock and available at current GBP prices shown live in the buy box above.
Before placing your order: open the BPC-157 peptide overview for full compound background, confirm your intended use falls within your institution's research ethics and COSHH framework, and retain all documentation for your procurement file. Then add your chosen format to cart on JCSG.org — UK dispatch, batch CoA included, research-grade Body Pharm quality guaranteed.
Buy Body Pharm BPC-157 5mg — Order Now
